Category: BIORISE
A Chinese Biotech Raises $90 M in Series A for CAR-T Cell Therapy Development
Shanghai-based biotech JW Therapeutics has raised $90 million in Series A funding round, led by Temasek, Sequoia Capital China, and ...
AI Startup Atomwise Raises $45 M in Series A Round to Accelerate Drug Discovery
KEY POINTS U.S. Based Atomwise raises $45 million in Series A funding round. Atomwise partners with big pharma and biotech ...
HDFC Backs MedGenome, Raises $40 Million in Series C Funding
DNA diagnostics firm, MedGenome has closed the Series C funding round at $40 million. The new investors HDFC Ltd, HDFC ...
Health-tech Startup LiveHealth Raises $1.1 Million in Seed Round
Pune-based health-tech startup, LiveHealth has raised $1.1 million from Nexus Venture Partners in the seed round. LiveHealth works towards digitization ...
2018 is the Make or Break Year for Bugworks Research: CEO
Introduction Bangalore based Bugworks Research is a drug discovery start-up aims to develop powerful new antibiotics against the world’s deadliest superbugs. ...
3D Bioprinting Biotech Pandorum Raises $3.6 M, Aims to Reach Market
KEY POINTS Pandorum targets to bring innovation in tissue engineering and regenerative medicine space. Pandorum is Medgenera’s one of the ...
HealthifyMe Raises $12 M in Series B Round
HealthifyMe New Funding Bangalore-based digital health and fitness startup, HealthifyMe has raised $12 million in a Series B funding round ...
A Serial Entrepreneur’ Practical Guidelines for a Pitch for Life-sciences Startup
INTRODUCTION Since capital is the lifeblood of your company, having a well-thought-out Pitch Deck is a vital asset for all ...
Interview: Genomics Services to Lead Indian Biotech Industry
Introduction Next-generation sequencing (NGS) and bioinformatics are set to take the genomic research and the overall biological field to the ...
J&J Establishes First JLABS in Europe to Help Healthcare Startups
KEY POINTS First JLABS established in Europe at the Beerse Janssen R&D Campus. Belgium-based JLINX incubator will transition to global ...